| MolName | 5-amino-6-[(Z)-indol-3-ylidenemethyl]-2-(2-morpholin-4-yl-2-oxoethyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one |
| MolecularFormula | C20H18N6O3S |
| Smiles | NC(N1N=C(CC(N2CCOCC2)=O)SC1=N1)=C(/C=C2/c(cccc3)c3N=C2)C1=O |
| InChI | InChI=1S/C20H18N6O3S/c21-18-14(9-12-11-22-15-4-2-1-3-13(12)15)19(28)23-20-26(18)24-16(30-20)10-17(27)25-5-7-29-8-6-25/h1-4,9,11H,5-8,10,21H2 |
| InChIK | KQJFPBOPBOUCRE-UHFFFAOYSA-N |
| TotalMolweight | 422.468 |
| Molweight | 422.468 |
| MonoisotopicMass | 422.116109 |
| CLogP | 0.0803 |
| CLogS | -3.246 |
| H Acceptors | 9 |
| H Donors | 1 |
| TotalSurfaceArea | 298.5 |
| Relative PSA | 0.37008 |
| PolarSurfaceArea | 138.25 |
| Druglikeness | 6.8434 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.56667 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 3 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 7 |
| Symmetricatoms | 2 |
| Amides | 1 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 5-amino-6-[(Z)-indol-3-ylidenemethyl]-2-(2-morpholin-4-yl-2-oxoethyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one | 2 - 5-amino-6-[(Z)-indol-3-ylidenemethyl]-2-(2-morpholin-4-yl-2-oxoethyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one